You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)

Article metrics

Article menu

Download PDFPDF

Poster Presentation
A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020031
Mar 2020010
May 2020010
Jun 2020041
Jul 2020010
Sep 2020060
Oct 2020010
Nov 2020020
Dec 2020010
Jan 2021020
Feb 2021002
Mar 2021011
Apr 2021040
May 2021032
Jun 2021001
Jul 2021010
Aug 2021031
Sep 2021020
Oct 2021026
Nov 20210212
Dec 2021036
Jan 20220311
Feb 2022018
Mar 2022018
Apr 2022013
May 2022078
Jun 2022033
Jul 2022022
Aug 2022041
Sep 2022037
Oct 2022053
Nov 2022040
Dec 2022061
Jan 2023023
Feb 2023040
Mar 2023020
Apr 2023011
Jun 2023020
Jul 2023015
Aug 2023021
Sep 2023040
Oct 2023001
Nov 2023061
Dec 2023020
Jan 2024041
Feb 2024092
Mar 20240725
Total0133129